The infralimbic cortex and mGlu5 mediate the effects of chronic intermittent ethanol exposure on fear learning and memory

Autor: C E Smiley, Justin T. Gass, N Otero, R J Newsom, T Valvano, Justin T. McGonigal
Rok vydání: 2020
Předmět:
Zdroj: Psychopharmacology (Berl)
ISSN: 1432-2072
0033-3158
Popis: RATIONALE AND OBJECTIVES: Alcohol use disorder (AUD) and post-traumatic stress disorder (PTSD) often occur comorbidly. While the incidence of these disorders is increasing, there is little investigation into the interacting neural mechanisms between these disorders. These studies aim to identify cognitive deficits that occur as a consequence of fear and ethanol exposure, implement a novel pharmaceutical intervention, and determine relevant underlying neurocircuitry. Additionally, due to clinical sex differences in PTSD prevalence and alcohol abuse, these studies examine the nature of this relationship in rodent models. METHODS: Animals were exposed to a model of PTSD+AUD using auditory fear conditioning followed by chronic intermittent ethanol exposure (CIE). Then, rats received extinction training consisting of multiple conditioned stimulus presentations in absence of the shock. Extinction recall and context induced freezing were measured in subsequent tests. CDPPB, a metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulator, was used to treat these deficits, and region-specific effects were determined using microinjections. RESULTS: These studies determined that CIE exposure led to deficits in fear extinction learning and heightened context induced freezing while sex-differences emerged in fear conditioning and extinction cue recall tests. Further, using CDPPB, these studies found that enhancement of infralimbic (IfL) mGlu5 activity was able to recover CIE induced deficits in both males and females. CONCLUSIONS: These studies show that CIE induces deficits in fear-related behaviors and that enhancement of IfL glutamatergic activity can facilitate learning during extinction. Additionally, we identify novel pharmacological targets for the treatment of individuals who suffer from PTSD and AUD.
Databáze: OpenAIRE